Jefferies Financial Group’s Novo Nordisk NVO Stock Holding History

Jefferies Financial Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-80,000	Closed	-$4.07M	–	2073
2025 Q4	$4.07M	Buy	+80,000	New	+$4.09M	0.02%	548
2025 Q3	–	Sell	-10,000	Closed	-$690K	–	1612
2025 Q2	$690K	Buy	+10,000	New	+$680K	0.01%	823
2025 Q1	–	Sell	-83,300	Closed	-$7.17M	–	1886
2024 Q4	$7.17M	Buy	83,300 +80,000	+2,424%	+$8.65M	0.04%	279
2024 Q3	$393K	Buy	+3,300	New	+$440K	﹤0.01%	1045
2024 Q1	–	Sell	-141,600	Closed	-$14.6M	–	1894
2023 Q4	$14.6M	Buy	+141,600	New	+$14M	0.1%	153

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jefferies Financial Group's NVO Position: Q2 2026 in Review

Jefferies Financial Group sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 16,524 shares — an estimated $607K sold.

Jefferies Financial Group first reported a position in NVO in Q4 2022 and held it in 14 quarters. The position peaked at $2.29M in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Jefferies Financial Group reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
Jefferies Financial Group sold 16,524 Novo Nordisk shares in Q2 2026, an estimated $607K.
Jefferies Financial Group first reported a position in Novo Nordisk in Q4 2022 and held it in 14 quarters.
Jefferies Financial Group's Novo Nordisk position peaked at $2.29M in Q3 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.